Xenon Pharmaceuticals Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Dec 2011 | — | $-86.3M | $13.9M |
| Dec 2012 | — | $-89.9M | $60.2M |
| Sep 2013 | — | — | $43.6M |
| Dec 2013 | — | $-78.4M | $38.0M |
| Mar 2014 | — | — | $34.9M |
| Jun 2014 | — | — | $35.1M |
| Sep 2014 | — | $-67.5M | $33.7M |
| Dec 2014 | — | $72.8M | $72.0M |
| Mar 2015 | — | $62.7M | $65.9M |
| Jun 2015 | — | $64.3M | $64.3M |
| Sep 2015 | — | $64.5M | $65.5M |
| Dec 2015 | — | $61.0M | $58.7M |
| Mar 2016 | — | $58.2M | $56.1M |
| Jun 2016 | — | $52.7M | $35.2M |
| Sep 2016 | — | $69.3M | $54.1M |
| Dec 2016 | — | $63.9M | $17.1M |
| Mar 2017 | — | $57.2M | $20.2M |
| Jun 2017 | — | $50.5M | $23.1M |
| Sep 2017 | — | $43.3M | $14.7M |
| Dec 2017 | $6.1M | $35.9M | $20.5M |
| Mar 2018 | $5.5M | $28.5M | $17.2M |
| Jun 2018 | $11.7M | $50.6M | $47.4M |
| Sep 2018 | $14.9M | $111.2M | $88.0M |
| Dec 2018 | $15.0M | $103.3M | $67.8M |
| Mar 2019 | $15.1M | $92.3M | $52.2M |
| Jun 2019 | $13.2M | $82.8M | $37.1M |
| Sep 2019 | $11.8M | $74.6M | $37.7M |
| Dec 2019 | $10.9M | $92.0M | $24.8M |
| Mar 2020 | — | $188.0M | $60.5M |
| Jun 2020 | — | $189.3M | $44.2M |
| Sep 2020 | — | $182.0M | $15.1M |
| Dec 2020 | — | $171.4M | $45.0M |
| Mar 2021 | — | $276.3M | $88.0M |
| Jun 2021 | — | $257.0M | $82.9M |
| Sep 2021 | — | $248.9M | $87.8M |
| Dec 2021 | — | $550.0M | $175.7M |
| Mar 2022 | — | $541.9M | $116.5M |
| Jun 2022 | — | $785.8M | $370.0M |
| Sep 2022 | — | $753.1M | $103.5M |
| Dec 2022 | — | $721.5M | $57.2M |
| Mar 2023 | — | $686.9M | $69.5M |
| Jun 2023 | — | $646.5M | $64.6M |
| Sep 2023 | — | $636.6M | $99.6M |
| Dec 2023 | — | $927.9M | $148.6M |
| Mar 2024 | — | $887.7M | $58.9M |
| Jun 2024 | — | $844.0M | $136.7M |
| Sep 2024 | — | $797.8M | $87.6M |
| Dec 2024 | — | $754.9M | $142.7M |
| Mar 2025 | — | $704.0M | $116.7M |
| Jun 2025 | — | $634.0M | $135.4M |
| Sep 2025 | — | $559.5M | $104.5M |
| Dec 2025 | — | $581.8M | $199.2M |
| Mar 2026 | — | $1.34B | $545.9M |
| Jun 2026 | — | $1.24B | $119.5M |